Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesSerum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis
Journal of Rheumatology, 09/11/09
Masi L et al. – Serum levels of OPN at baseline represent a possible marker to predict the responsiveness to MTX in patients with JIA.
Methods- At diagnosis, 60 children with active JIA received MTX in addition to nonsteroidal antiinflammatory drugs
- After 12 months of MTX treatment, 30 patients were defined as responders; the 30 nonresponders received anti-tumor necrosis factor-? therapy (etanercept) in addition to MTX; this group was then enrolled for an additional 12-month study period
- No patient had received steroids within 6 weeks before entering the study
- Fifty healthy children matched for sex and age acted as controls
- OPN serum levels were measured at baseline, before MTX, and then at 6 and 12 months
- In the nonresponder patients, OPN was evaluated again after 6 and 12 months of etanercept treatment
- At baseline, OPN values were significantly higher in JIA patients than in controls, with no significant differences among the different JIA subtypes
- At baseline, OPN levels were lower in responders than in nonresponder patients (14.16 ± 10.1 µg/ml vs 33.2 ± 18.1 µg/ml, respectively)
- After 12 months of MTX treatment, OPN levels were significantly reduced in comparison to baseline in both responder and non-responder groups
- In non-responders, etanercept significantly reduced OPN levels at 6 and 12-month followup in comparison to baseline
- No significant differences were found among OPN levels and disease activity
Related Articles
Rituximab Therapy Produced Rapid and Sustained Clinical Improvement in a Patient With Systemic Onset Juvenile Idiopathic Arthritis Refractory to TNF Alpha Antagonists
Journal of Clinical Rheumatology (JCR), 10/09/09
Relevance Score: 81%
New Study Detects No Invasive Cancer Risk in Juvenile Arthritis Patients
MedLinePlus, 11/03/09
Relevance Score: 80%
New Treatment Combination Promising for Children with Arthritis
MedLinePlus, 11/03/09
Relevance Score: 80%
Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis
Arthritis Care and Research, 11/02/09
Relevance Score: 80%
Analysis of quantitative ultrasound graphic trace and derived variables assessed at proximal phalanges of the hand in healthy subjects and in patients with cerebral palsy or juvenile idiopathic arthritis. A pilot study
Bone, 10/08/09
Relevance Score: 80%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Plasma level of myeloperoxidase in children with juvenile idiopathic arthritis (a pilot study)
Central European Journal of Medicine, 11/25/09
Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
Osteoporosis International, 11/25/09
Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis
International Journal of Rheumatic Diseases, 11/25/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: A prospective study
Osteoporosis International, 11/25/09
Treatment of osteoporosis: Recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
Osteoporosis International, 11/25/09
Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
Osteoporosis International, 11/25/09
Today in Pediatric Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Plasma level of myeloperoxidase in children with juvenile idiopathic arthritis (a pilot study)
Central European Journal of Medicine, 11/25/09
The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: A pilot study
Rheumatology, 11/24/09
Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study
Rheumatology, 11/23/09
Sponsor
Article Search
Sponsor